Table of Contents Table of Contents
Previous Page  385 476 Next Page
Information
Show Menu
Previous Page 385 476 Next Page
Page Background

whilst confirming hospital-level effects contributed signifi-

cantly. For process-based QIs, such as PN and MIS, this may

reflect that surgeon preference and access to resources as

opposed to patient or tumor characteristics are driving

treatment decisions. Furthermore, a volume-quality rela-

tionship may explain the variation observed, as supported

by the finding that superior-outlier hospitals were associ-

ated with higher surgical volumes for all QIs aside from the

LOS indicator. This is consistent with previous reports,

demonstrating higher surgical volume and academic

affiliation are associated with the uptake of PN

[18,19]

. Hence, while the underlying mechanism driving

quality variation could not be addressed directly, the

aforementioned factors warrant further investigation as

causal factors. Such data has important implications

regarding decisions surrounding the centralization of RCC

surgery to high volume or academic centers.

According to the Donabedian model, ideal QIs not only

capture variations in care, but further demonstrate con-

struct validity through being associated with known

structural, process, or outcome elements of health care

delivery

[20]

. For all QIs analyzed, construct validity could

be demonstrated to varying degrees with superior perfor-

mance being associated with greater hospital volume,

academic status, or lower mortality (30-d, 90-d, overall).

We argue that a systematic data-driven approach as

reported here, which determines the construct validity of

putative QIs, should be implemented by policymakers to

prioritize QIs for inclusion in benchmarking strategies.

Composite measures encompassing multiple validated

QIs will likely be required to comprehensively capture

quality-outcome relationships

[21]

. This is consistent with

the minimal concordance observed between the QIs studied

here

( Fig. 2

), highlighting that each captures a unique aspect

of RCC quality care. To address this, we developed a

composite measure of RCC surgical quality incorporating all

QIs analyzed in this study, the RC-QS. We included all

individual QIs as each displayed interhospital discrimina-

tion and construct validity by association to a structural or

outcome quality element. Importantly, construct validity

was determined for the RC-QS as a positive score associated

with both structural and outcome measures, including

improved patient survival. Notably, further improvements

to the RC-QS could be adopted through a similar analysis as

represented here as more QIs are validated. As such, we

envision this work as an initial step requiring ongoing and

dynamic improvements towards the creation of a quality-

benchmarking program for RCC surgery, with population-

level databases such as the NCDB serving as practical

vehicles to disseminate the RC-QS.

This study has several limitations. First, NCDB data

[42_TD$DIFF]

are

retrospective with certain case-mix factors not captured,

including tumor complexity and renal function. These

factors may influence QI performance and were not

controlled for

[18,19,22] .

Retrospective data are also

subject to reporting bias, which may particularly affect

PMR. Further, individual surgeon characteristics, referral

patterns, and care networks could not be assessed given

their absence in the NCDB. This is particularly relevant for

the PN and MIS indicators as surgeons may refer patients

due to a lack of experience or resources, contributing to a

poor quality score. Moreover, while quality-mortality

associations were captured, additional important patient

outcomes (eg, in-hospital complications, cancer-specific

survival) could not be assessed given their absence from

the NCDB. Lastly, similar quality assessments utilizing

population level databases outside the USA are required

to confirm the external validity of our results.

5.

Conclusions

In conclusion, nationwide variations in RCC surgical quality

exist on a hospital-level. These variations are captured by

the RC-QS, a validated RCC specific composite measure of

quality readily determined from the NCDB. Although

assessments of quality variation between hospitals can

engender controversy, ongoing healthcare delivery im-

provement cannot occur without accurate measure and

feedback. These results support the use of the RC-QS as a

quality benchmarking tool for RCC surgery that provides

audit level feedback to hospitals and policymakers for

quality improvement.

This work was accepted for presentation at the 2017 American

Urological Association and Canadian Urological Association Annual

Meetings.

Author contributions:

Antonio Finelli had full access to all the

data in the study and takes responsibility for the integrity of the data and

the accuracy of the data analysis.

Study concept and design:

Lawson, Saarela, Abouassaly, Finelli.

Acquisition of data:

Lawson, Saarela, Abouassaly, Kim, Finelli.

Analysis and interpretation of data:

Lawson, Saarela, Abouassaly, Kim,

Breau, Finelli.

Drafting of the manuscript:

Lawson, Saarela, Finelli.

Critical revision of the manuscript for important intellectual content:

Lawson, Saarela, Abouassaly, Kim, Breau, Finelli.

Statistical analysis:

Lawson, Saarela, Abouassaly, Finelli.

Obtaining funding:

Abouassaly, Finelli.

Administrative, technical, or material support:

None.

Supervision:

Saarela, Abouassaly, Finelli.

Other:

None.

Financial disclosures:

Antonio Finelli certifies that all conflicts of

interest, including specific financial interests and relationships and

affiliations relevant to the subject matter or materials discussed in the

manuscript (eg, employment/affiliation, grants or funding, consul-

tancies, honoraria, stock ownership or options, expert testimony,

royalties, or patents filed, received, or pending), are the following:

None.

Funding/Support and role of the sponsor:

None.

Acknowledgments:

This work was supported by funds from the Princess

Margaret Cancer Centre Foundation.

Appendix A. Supplementary data

Supplementary data associated with this article can be

found, in the online version, at

http://dx.doi.org/10.1016/j. eururo.2017.04.033

.

E U R O P E A N U R O L O G Y 7 2 ( 2 0 1 7 ) 3 7 9 – 3 8 6

385